recombinant_EgKI-1
in_model
EgKI-1_treatment
cell_cycle
member
EgKI-1
model
significant_tumor_growth_reduction
Women
Cochrane_Library
aim
females
personal_goal-setting
Women_'s_personal_goals
literature
study_population
effect
Women_'s_goals
interventions_measurement_tools_outcomes
women
goal-setting
estrogen_receptor_patients
treatment
estrogen_receptor_positive_patients
cell_cycle
combined_treatment
co-treatment
cell_migration
Tamoxifen
we
naringenin_treatment_group
Breast_cancer
naringenin
cell_proliferation
cell_growth
cells
second-leading_cause
investigated
exponential
proposed_digital_phantom
corresponding_time-enhancement_curves
modality
sources
purpose
uniform_random_distribution
digital_phantom
distribution
tumor_models
breast_lesion_model
4D
uniform_distribution
typical_4D
random_distribution
×
3D_static_phantom
characteristics
perfusion
3D_phantom
4D_array
patterns
corresponding_curves
detection_diagnosis
arterial_sources
different_patterns
phantom
curves
proposed_phantom
Results
time-enhancement_curves
4D_phantom
typical_4D_phantom
using
potent_activity
pallidus
activity
aqueous_Orthosiphon_pallidus_extract
objective
total
Orthosiphon_pallidus_extract
percent_cytotoxicity
activities
antioxidant_activity
anticancer_activities
Orthosiphon_pallidus
damage
study
61.6_%
patients
196_patients
67.1_%
anthracycline-based_adjuvant_therapies
serious_damage
Cox
80.6_%
p
67.9_%
DFS_rate
retrospective_study
women
patients
Most_patients
analysis
Patient_self-reports
prognosis_discussions
T-PAT_clinicians
effects
Audio_analysis
clinicians
Female_patients
Productive_prognosis_discussions
T-PAT_participants
preparations
repeated_chromatographic_preparations
repeated_preparations
Cancer_stem_cells
chromatographic_preparations
findings
Targeting_breast_CSCs
aldehyde_dehydrogenase
compound
CSCs
Acute_skin_toxicities
December_2015_787_consecutive_patients
Cosmetic_outcomes
skin_toxicities
patients
association
G1
G2
VMAT-SIB
Patients
outcomes
Our_data
Hypofractionated_VMAT-SIB
December_2015_787_patients
cosmetic_outcomes
recurrences
Gene_Set
Enhanced_understanding
multigene_assays
assays
Higher_expression
their_association
estrogen_receptor
recurrence_risk
side_effects
late_recurrence_selection_tools
5_years
endocrine_therapy
Extended_therapy
understanding
Enrichment_Analysis
predicting
several_clinicopathological_parameters
late_recurrence_risk
expression
therapy
several_parameters
patients
late_recurrences
clinicopathological_parameters
diagnosis
benefit
Long-term_intervention
effects
Extended_endocrine_therapy
effect
recurrence_selection_tools
risk
intervention
parameters
showing
treatment
data
anti-estrogen_therapy
mTOR_inhibitor_everolimus
management_challenges
research
known
majority
backbone
deaths
therapies
therapy
selective_estrogen_receptor_modulators
PI3K/AKT/mTOR_pathway
patients
important_growth_pathway
quality
agents
supportive_care
Analysis
pathway
Endocrine_therapy
care
Ongoing_research
Women
study
circumstances
cases
average_time
primary_dysfunctions
dysfunctions
changes
Their_average_age
Sexual_function
Two-thirds
p
514_women
sexual_dysfunctions
instruments
function
time
main_problems
Their_age
women
participants
primary_sexual_dysfunctions
problems
posttranslational_modifications_interactions
ERα_polyubiquitination_estrogen_receptor_degraders
transcriptional_regulator
activity
may_key_factor
inhibition
specific_protein_complexes
increase
its_signaling
related
Estrogen_receptor_alpha
polyubiquitination
regulator
extranuclear_activity
ERα_polyubiquitination
ERα_polyubiquitination_selective_estrogen_receptor_degraders
events
ERα_polyubiquitination_inhibition
aim
adjuvant_accelerated_breast_irradiation
Its_potential_practical_applications
changes
Their_treatment-related_cosmetic_changes
accelerated_breast_irradiation
adjuvant_partial_breast_irradiation
One_photograph
adjuvant_breast_irradiation
breast_irradiation
accelerated_partial_breast_irradiation
further_investigation
Their_cosmetic_changes
adjuvant_accelerated_partial_breast_irradiation
patients
OBCS
partial_breast_irradiation
female_patients
Nineteen_female_patients
Agreement
intraclass_correlation_coefficient
photograph
photographs
coefficient
correlation_coefficient
Its_potential_applications
several_aspects
breast_cancer_cells
study
expression
proliferation
S961
IR_mRNA_expression_levels
aspects
mRNA_expression
IR_antagonist_S961
Insulin_resistance
upregulated_expression
IR_signalling
effect
breast_radiotherapy
treatment
Immediate_Verbal_Memory_Index
Pearson
adjuvant_breast_radiotherapy
The_Delayed
Memory_decline
changes
association
mechanisms
three_visual_representations
three_representations
CXCL1_expression
therapeutic_targets
high_CXCL1_expression
CXCL1
significant_reduction
targets
QPCR_screening
macrophages
epithelial-mesenchymal_transition
Tumor-associated_macrophages
have_implicated
TAMs/CXCL1
CXCL1_silencing
4_patients
other_4_patients
eribulin_mesylate
doses
patients
3_patients
Level_1_group
efficacy
we
other_patients
I_clinical_study
Japanese_patients
dose
combination_therapy
tolerability
ERI
combination
Breast_cancer
evidence
type

